ClinicalTrials.Veeva

Menu

Amniotic Fluid Lactate in Perterm Premature Rupture of Membranes

A

Ain Shams University

Status

Unknown

Conditions

Rupture of Membranes; Premature

Treatments

Diagnostic Test: amniotic fluid lactate

Study type

Interventional

Funder types

Other

Identifiers

NCT03789903
ain shams maternity hos

Details and patient eligibility

About

AF lactate level could help in predicting the duration from ROM till delivery

Enrollment

80 estimated patients

Sex

Female

Ages

25 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. women with PPROM
  2. GA between 24 to 34 weeks

Exclusion criteria

  1. chorioamnionitis
  2. previous Preterm labor
  3. abruptio placentae
  4. UTI ,pyelonephritis

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Radwa R Ali, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems